Articles and Blogs

On behalf of Hall Render’s real estate service line, Joel and I want to thank you for being a loyal subscriber to our Weekly Health Care Real Estate Briefing. We have enjoyed producing the briefing over the past year and appreciate the feedback you have provided to us. In previous years, we have produced a…Read More

On December 18, 2023, the Federal Trade Commission and the Antitrust Division of the Department of Justice (together, the “Agencies”) released their finalized Merger Guidelines (the “Final Guidelines”). The Final Guidelines contain updates to the draft merger guidelines (the “Proposed Guidelines”) that the Agencies released in July 2023. The Final Guidelines are a significant shift…Read More

Under the federal Stark Law, hospitals, physician groups, labs and other provider entities may provide non-monetary (i.e., non-cash or cash equivalent) compensation to physicians up to an aggregate amount of $507 for calendar year 2024. The dollar limit for “medical staff incidental benefits” provided by a hospital to a member of its medical staff (e.g.,…Read More

On November 17, 2023, the Centers for Medicare & Medicaid Services (“CMS”) finalized its proposed rule (“Final Rule”), found here, implementing certain sections of the Affordable Care Act to require the disclosure of certain ownership, managerial and other information regarding Medicare-participating skilled nursing facilities (“SNFs”) and Medicaid-participating nursing facilities (“NFs”). As previously summarized by Hall…Read More

S&P Global Ratings published a sector view report on the nonprofit hospital sector, indicating the agency expects a constrained operating environment in 2024 largely due to persistently high labor and operating costs. Another factor behind the negative outlook is that health care providers are restarting deferred capital projects and potentially looking to debt to help…Read More

Starting January 1, 2024, many privately-owned entities will be exposed to ongoing disclosure and reporting obligations required by the Corporate Transparency Act (“CTA”). The goal of the CTA is to strengthen national security and the integrity of the U.S. financial system by making it more difficult for illicit actors to use shell companies for money…Read More

The Federal Reserve agreed to hold its benchmark interest rate while signaling that rate cuts may be in the cards for 2024. If economic conditions continue to improve, the Federal Reserve plans to reduce interest rates by .75% in 2024. After the news broke, the stock market rallied and real estate investors expressed new optimism…Read More

After a slow start to the year, the Food and Drug Administration’s (“FDA”) Office of Prescription Drug Promotion (“OPDP”) now has a total of five enforcement letters for 2023 (four Untitled Letters and one Warning Letter) with potentially the last two letters of 2023 issued on Halloween. Our summary of the first three letters can…Read More